Journal article
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2025
APA
Click to copy
Ramalingam, A. R., Kucera, C., Srivastava, S., Paily, R., Stephens, D., Lorkiewicz, P., … Carll, A. (2025). Acute and Persistent Cardiovascular Effects of Menthol E‐Cigarettes in Mice. Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
Chicago/Turabian
Click to copy
Ramalingam, Anand R, Cory Kucera, Shweta Srivastava, Romith Paily, Dawson Stephens, Pawel Lorkiewicz, D. Wilkey, Michael Merchant, Aruni Bhatnagar, and A. Carll. “Acute and Persistent Cardiovascular Effects of Menthol E‐Cigarettes in Mice.” Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease (2025).
MLA
Click to copy
Ramalingam, Anand R., et al. “Acute and Persistent Cardiovascular Effects of Menthol E‐Cigarettes in Mice.” Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2025.
BibTeX Click to copy
@article{anand2025a,
title = {Acute and Persistent Cardiovascular Effects of Menthol E‐Cigarettes in Mice},
year = {2025},
journal = {Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease},
author = {Ramalingam, Anand R and Kucera, Cory and Srivastava, Shweta and Paily, Romith and Stephens, Dawson and Lorkiewicz, Pawel and Wilkey, D. and Merchant, Michael and Bhatnagar, Aruni and Carll, A.}
}
Background Although e‐cigarettes provide an alternative to conventional smoking, the cardiovascular impacts of e‐cigarette use are unresolved. The popularity of menthol e‐cigarettes has surged recently and may escalate further with bans on combustible menthol cigarettes and e‐cigarette flavors other than menthol and tobacco. Despite recent evidence in mice that menthol e‐cigarettes acutely induce cardiac arrhythmias, the impacts of repeated menthol e‐cigarette use on cardiovascular function and the cardiac proteome remain unclear. We therefore investigated the acute and persistent cardiovascular effects of menthol e‐cigarettes in a mouse model. Methods and Results Adult C57BL/6J mice with ECG and blood pressure radiotransmitters were exposed to e‐cigarette aerosols (180–270 puffs/day; n=4–8/group). One‐day exposures to nicotine‐containing e‐cigarette aerosols depressed heart rate variability regardless of flavor, but menthol e‐cigarette aerosols uniquely increased heart rate and urine epinephrine and elicited spontaneous ventricular premature beats. Menthol e‐cigarette aerosols consistently increased blood pressure acutely, and this effect recurred throughout the 20‐day regimen. Pretreatment with atenolol abolished e‐cigarette–induced arrhythmias, suggesting the involvement of β1‐adrenoceptors. After 4 weeks of exposure to JUUL Menthol aerosol, mice had basal sinus bradycardia that persisted up to 3 weeks after exposure cessation. After cessation, e‐cigarette–exposed mice also exhibited an altered chronotropic response to restraint stress and prolonged ventricular repolarization (corrected QT interval). Integrated proteomic and phosphoproteomic analysis of cardiac tissue harvested from mice exposed to menthol e‐cigarette aerosols for 5 and 20 days revealed molecular signatures of dilated and arrhythmogenic cardiomyopathy. Conclusions Exposure to menthol e‐cigarette aerosols induces persistent cardiovascular autonomic imbalance in vivo. These findings raise the possibility of similar effects in humans using mentholated e‐cigarettes.